Showing 1 - 10 results of 10 for search 'E. S. Nesterova', query time: 0.03s
Refine Results
-
1
Natriuretic peptide family. Options for use in outpatient practice by S. V. Ivanova, E. A. Nesterova
Published 2014-12-01
Article -
2
-
3
-
4
-
5
-
6
Register of Microorganisms as a Tool for Automated Antibiotics Consumption Planning and Monitoring of Antibiotic Resistance in Intensive Care Units and Specilized Hospital Departme... by O. E. Karpov, V. G. Gusarov, N. N. Lashenkova, N. V. Petrova, M. V. Dementienko, D. N. Shilkin, E. E. Nesterova, M. N. Zamyatin
Published 2017-01-01
Article -
7
-
8
P101: Combination of immune checkpoint inhibitors with BeGEV in the treatment of patients with relapsed and refractory classical Hodgkin’s lymphoma. by Ya.K. Mangasarova, T.N. Moiseeva, L.S. Al-Radi, O.V. Margolin, L.G. Gorenkova, E.S. Nesterova, M.O. Bagova, E.A. Fastova, R.R. Abdurashidova, Z.T. Sarakaeva, Elena Dorokhina, S.K. Kravchenko, A.U. Magomedova, E.E. Zvonkov
Published 2022-10-01
Article -
9
Comparative assessment of efficacy and toxicity of R-DA-EPOCH and R-mNHL-BFM-90 induction courses in the treatment of patients with diffuse large B-cell lymphoma with poor prognost... by M. O. Bagova, A. U. Magomedova, S. K. Kravchenko, Ya. K. Mangasarova, O. V. Margolin, E. S. Nesterova, L. G. Gorenkova, A. E. Misyurina, E. A. Fastova, F. E. Babaeva, K. A. Sychevskaya, S. M. Kulikov, Yu. A. Chabaeva, V. G. Savchenko
Published 2021-09-01
Article -
10
Follicular lymphoma: results of multicenter study of first-line therapy with bendamustine and rituximab, risk factors for adverse events (fl-rus-2013 protocol) by E. S. Nesterova, S. K. Kravchenko, A. M. Kovrigina, E. G. Gemdzhian, L. V. Plastinina, Ya. K. Mangasarova, F. E. Babaeva, A. E. Misyurina, O. V. Margolin, A. U. Magomedova, V. I. Vorobiev, D. S. Maryin, E. A. Baryakh, Yu. Yu. Polyakov, P. A. Zeynalova, E. M. Volodicheva, N. N. Glonina, N. V. Minaeva, G. A. Davydova, V. G. Savchenko
Published 2018-10-01
Article